Skip to Content

Clinical Trial Details


ACP-196 Alone and in Combination With Pembrolizumab in Subjects With Recurrent Ovarian Cancer (KEYNOTE191)


Request Additional Trial Information
Full Trial Details:

Condition: Ovarian Cancer
Study Type: Interventional
Phase: Phase II
Study Start Date: 08/28/2015
Study Completion Date: TBD

To characterize the safety and efficacy of ACP 196 monotherapy and ACP-196 plus pembrolizumab in subjects with recurrent ovarian cancer.

NCT Number
Principal Investigator(s)
Frederick Min, MD
Acerta Pharma BV
Participant Eligibility
  • Age: 18 - No Maximum
  • Gender: Female


  • Shady Grove Adventist Aquilino Cancer Center
    9905 Medical Center Drive
    Rockville, MD 20850
    Main: 240-826-6297

Clincal Trials & Research Studies

Patient Stories

We’re writing new chapters in the lives of our patients, their families and our community daily. These are their stories:

Local Health News - In Your Inbox

Join over 47k of your friends & neighbors and get the latest news about community health programs and events when you sign-up for Adventist HealthCare & You Digital.

Subscribe Today!